Clinical Trial Update: Peginesatide for Anemia in Chronic Hemodialysis Patients [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating peginesatide for anemia in chronic hemodialysis patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• OMontys (peginesatide)

Snippet

Sponsor: Affymax | Conditions: Anemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED